Status:
RECRUITING
Glyceryl Eicosapentaenoate Based Topic Products As an Irritant-free Cream and Serum for Hydration of Sensitive Skin
Lead Sponsor:
SCF Pharma
Collaborating Sponsors:
Institut de recherche clinique du littoral (IRCL)
Conditions:
Skin Dryness
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This exploratory study aims to verify the hydrating potential as well as the possible irritant effects of a 14-day hydrating treatment consisting of daily application of serum and cream to the skin of...
Detailed Description
The aim of this study is to verify the moisturizing potential of three different creams containing glyceryl eicosapentaenoates when used as a moisturizing treatment combined with a glyceryl eicosapent...
Eligibility Criteria
Inclusion
- Participant aged between 18 and 65 years old.
- Participant who reports having dry skin.
- Available for the entire duration of the study and willing to participate based on the information provided in the informed consent form duly read and signed by the latter.
- Participant not presenting intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff.
Exclusion
- Participant with a skin disease diagnosed by their treating physician and who requires drug treatment.
Key Trial Info
Start Date :
July 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 7 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06219213
Start Date
July 25 2023
End Date
August 7 2025
Last Update
December 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de recherche clinique du littoral (IRCL)
Rimouski, Quebec, Canada, G0K 1P0